Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?

To: pompsander who wrote (754224)	11/13/2006 7:31:38 PM
From: DuckTapeSunroof	Respond to of 769667

Re: "The Wall Street Journal ran an OP-Ed piece today on how the government really couldn't lower drug prices by negotiating with the drug companies. I don't buy it at all. Every health consortium I have been involved with has had success in negotiating with providers when the size and buying power of the entity came into play. Just on generics the power of the government would be mammoth...and there would still be plenty of profit...just not quite as much for the drug companies. <g> If the WSJ is weighing in on a concept like this, it has to be something with some bite to it for corporate America." Pomp, I truly don't KNOW that the result will be one way or the other (as with most government policies... so much will depend upon how it's implemented and, as always, the Devil will be in the details). Still... the BEST indicator I have to go by is a negative indicator: Based SOLELY upon the MASSIVE AMOUNT of campaign contributions (90% or so going to Republicans, in an admitted attempt to block this change) that the pharmaceutical industry just forked over in this recent election cycle --- a new record! I'm betting that the pharmaceutical industry BELIEVES that much more money can be squeezed out of their drug prices. And, if ANYBODY ought to have an informed opinion about this, I'll bet it's Big Pharma! :-)